Web Search Site Search Ryan White Care Act Hepatitis C & B Language (click here for details)   Current HIV Articles and News Updates     HIV     IAC: Darunavir (DRV)/r-based Postexposure Prophylaxis (PEP) versus standard of care (SOC) - quality of life in patients receiving PEP in a randomized study (PEPDar) (07/30/14)   IAC: Economic Burden of Adverse Events Associated With HIV Antiretroviral Therapy in the United States (07/30/14)   IAC: Monocyte activation markers remain significantly elevated in virologically suppressed HIV+ individuals to a level equivalent to an additional 4 years of normal ageing (07/30/14)   IAC: Safety and Efficacy of the Integrase Inhibitor-Based Stribild Single-Tablet Regimen in HIV-Infected Adolescents Through 24 Weeks of Treatment (07/29/14)   IAC: Pharmacokinetics of Boosted-Elvitegravir in Combination with Rifabutin, Utilizing Twice Daily Administration of Cobicistat to Overcome Induction (07/29/14)   IAC: Romidepsin HDAC Inhibitor Stimulates HIV from Reservoirs in Hunt to Find HIV Cure (07/29/14)   IAC: Treatment with the histone deacetylase inhibitor Panobinostat markedly reduces chronic inflammation in HIV-infected patients (07/29/14)   More HIV Articles...         News Updates     HIV Groups File Federal Complaint Against Insurance Companies for "Discrimination" - "Overly Restrictive" "Unduly Limits Access", Charging High Copays & Coinsurance - (07/16/14)   US National Survey Results on Potential Barriers to HIV Treatment Use Announced Today - (06/30/14)   Cuomo Plan Seeks to End New York's AIDS Epidemic - (06/30/14)   More News Updates Articles...     Current Hepatitis C and B Articles     Hepatitis C     Daclatasvir+Sofosbuvir-new studies, VX135, Daclatasvir Phase 3 IFN-free, EMA Compassionate Use, Accelerated EMA Marketing Review Recommendation   IAC: Lack of Clinically Relevant Drug Interactions Between Elvitegravir plus Ritonavir Boosted-Atazanavir and Telaprevir (07/30/14)   Around 4 million Vietnamese people suffer hepatitis C - (07/30/14)   Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study - (07/30/14)   All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study - (07/30/14)   Global Distribution & Prevalence of HCV Genotypes - (07/30/14)   HCC Risk - (07/30/14)   NHANES: "non-Hispanic blacks bore the greatest burden of HCV infection in the United States... IDU remains Strongest Risk Factor for HCV infection" - (07/30/14)   More Hep C Articles...         Hepatitis B     Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: Virological and clinical implications - (07/16/14)   Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B„A Nationwide Cohort Study - (07/16/14)   Averting Hepatocellular Carcinoma in Chronic Hepatitis B With Antiviral Therapy: Tipping the Balance or Not Yet? - (07/16/14)   More Hep B Articles...   Check Out Our Special NATAP Features   Link to conference listings 4th HIV & Women Workshop 2014 13 January 2014 - 14 January 2014 Washington DC, USA 4th HIV & Women Workshop 2014 CROI 2014 - 21st Conference on Retroviruses and Opportunistic Infections http://www.croi2014.org/ Conference on Retrovirueses and Opportunistic Infections Asian Pacific Association for The Study of the Liver Brisbane 12 - 15 March 2014 http://www.apasl2014.com/ 12th European HIV & Hepatitis Workshop 2014 Barcelona, Spain on 26 - 28 March 2014 12th European HIV & Hepatitis Workshop 2014 2nd International Workshop on the Optimal Use of DAA's in Advanced Liver Disease and Transplantation London, UK, on 8 April 2014 2nd DAA's in Hep Transplant EASL 2014 - 49th Annual Meeting of the European Association for the study of the Liver London, United Kingdom. April 9-13 EASL 2014 Annual Congress 9th Hepatitis C Workshop 2014 13 April 2014 in London, United Kingdom 3rd World Congress on Controversies in the Management of Viral Hepatitis Berlin, Germany May 1-3 2014 http://www.comtecmed.com/chep/2014/Default.aspx DDW - Digestive Disease Week May 3-6 2013 Chicago, Illinois http://www.ddw.org/ American Conference for the Treatment of HIV (ACTHIV) May 8-10 2014, Denver CO http://www.acthiv.org/ HIV in the Americas Congress 7-10 May 2014 Rio de Janeiro, Brazil HIV in the Americas 2014 8th International Workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource-poor Settings 5 May 2014 - 9 May 2014 Lusaka, Zambia 8th Interest Meeting 2014 3rd ACHA conference, the Asian Conference on Hepatitis and AIDS - From Basic 9 and 10 May 2014 Beijing, China 3rd ACHA Conference 2014 15th International Workshop on Clinical Pharmacology of HIV & Hepatitis 19 May 2014 - 21 May 2014 Washington DC, USA www.virology-education.com 3rd Latin American Meeting on Treatment of Viral Hepatitis Sao Paulo, Brazil 6-7 June 2014 http://www.virology-education.com/event/upcoming/3rd-la-viral-hepatitis-workshop-2014/ 10th International Workshop on HIV & Hepatitis Co-infection 2 - 13 June 2014 Paris, France http://www.virology-education.com/event/upcoming/10th-co-infection-workshop-2014/ 20th International AIDS Conference July 20-25 2014 Melbourne, Australia http://www.aids2014.org/ ICAAC 2013 - 54th Interscience Conference on Antimicrobial Agents and Chemotherapy September 6-9, 2014 Washington, D.C. 20001, United States www.icaac.org/ 16th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV 6 - 8 October, in Philadelphia, USA. The venue is the Hyatt Regency, Penn's Landing. http://www.intmedpress.com/comorbidities/ IDSA ID Week 2014: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS 10/08/2014 - 10/12/2014 Philadelphia, PA IDWeek 2014 about idweek > IDWeek 2014 HIV & Aging: From Mitochondria to the Metropolis Emory University, October 2-3, 2014, Atlanta, GA http://nursing.emory.edu/news/events/hiv-aging/index.html The Viral Hepatitis Congress 2014 9-11 October 2014 Frankfurt, Germany The Viral Hepatitis Congress 2014 5th International Workshop on HIV & Aging 20 - 21 October 2014 Baltimore, MD, USA http://www.virology-education.com/event/upcoming/5th-hiv-aging-2014/ HIV Glasgow 2014 2-6 November 2014 Glasgow, United Kingdom HIV Drug Therapy 2014 (Glasgow) 1st International Hepatitis Cure & Eradication Meeting 2014 6 and 7 Novemer 2014 Toronto, Canada http://www.virology-education.com/event/upcoming/1st-international-hepatitis-cure-eradication-meeting-2014/ AASLD - the 65th Annual Meeting of the American Association for the study of Liver Diseases Nov 7-11 Boston MA http://www.aasld.org/livermeeting/Pages/default.aspx 20th International AIDS Conference July 20-25, 2014 Melbourne, Australia   International Workshop on Antiviral Drug Resistance June 3-7 2014, Berlin, Germany   15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy May 19- 21, 2014, Washington, DC   DDW - Digestive Disease Week 2014 May 4, 2014, Chicago Illinois, United States   EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom April 9-13   (APASL) 24th Conference of the Asian Pacific Association for the Study of the Liver Brisbane, Australia 12-15 March, 2014   21st Conference on Retroviruses and Opportunistic Infections Boston MA March 3 - 6, 2014   6th HIV Persistence during Therapy - Sixth International Workshop Miami, Dec 3-6, 2013   Fourth International Workshop on HIV and Women January 13-14, 2014 Washington DC   HEPDART 2013: Frontiers in Drug Development for Viral Hepatitis December 8-12, 2013 Big Island, Hawaii   64rd Annual Meeting of the American Association for the Study of Liver Diseases Washington, DC Nov 1-5 2013   4th International Workshop on HIV and Aging October 30-31, 2013 Baltimore, MD   14th European AIDS Conference Oct 16-19 2013 Brussels, Belgium   ID Week October 2-6, 2013 San Francisco   53rd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy September 10-13 2013, Denver CO   IAS 2013: 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention June 30 - July 3 2013 Kuala Lumpur, Malaysia   International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies June 4-8, 2013 Toronto, Canada   (APASL) 23rd Conference of the Asian Pacific Association for the Study of the Liver 6-9 June, 2013, Singapore   Digestive Disease Week (DDW) May 18-21, 2013 Orlando, FL   14th International Workshop on Clinical Pharmacology of HIV Therapy April 22-24, 2013 The Netherlands, Amsterdam   EASL 48th Annual Meeting April 24th - 28th 2013 The Netherlands, Amsterdam   CROI: 20th Conference on Retroviruses and Opportunistic Infections Atlanta, GA March 3 - 6, 2013   Third International Workshop on HIV and Women January 14-15, 2013 Toronto 11th International Congress on Drug Therapy in HIV Infection 11-15 November 2012 Glasgow, UK 63rd Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 9-12 2012 3rd International Workshop on HIV and Aging November 5-6, 2012 Baltimore MD IDSA Conference (Infectious Disease Society Association) San Diego, CA Oct 17-21 2012 52nd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy September 9-12, 2012, San Francisco XIX International AIDS Conference July 22-27, 2012 Washington, DC   14th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV Washington DC, July 19-21 2012   International Workshop on HIV & Hepatitis Virus Drug Resistance 5-9 June 2012, Sitges, Spain   EASL 47th Annual Meeting Barcelona, Spain April 18th - 22nd 2012   13th International Workshop on Clinical Pharmacology of HIV Therapy Barcelona, Spain April 16-18, 2012   CROI: 19th Conference on Retroviruses and Opportunistic Infections Seattle, WA March 5 - 8, 2012   The 22st Conference of the Asian Pacific Association for the Study of the Liver APASL Feb 16-19, 2012 Taipei, Taiwan   2nd International Workshop on HIV & Women January 9-10, 2012 Bethesda, Maryland   HepDART 2011 Kauai, HI USA December 4, 2011 - December 8, 2011   62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9   Second International Workshop on HIV and Aging Baltimore, MD October 27-28, 2011   EACS - 14th European AIDS Conference European AIDS Conference Oct 12-15 2011 Belgrade, Serbiay   51th ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago, IL September 17-20, 2011   6th IAS Conference on HIV Pathogenesis Treatment and Prevention July 17-20, 2011, Rome   13th Intl Workshop on Adverse Reactions & Comorbidities in HIV July 2011-Rome, Italy   The 6th International Workshop on Clinical Pharmacology of Hepatitis Therapy Boston, MA June 22-23, 2011   International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies June 7- 11, Cabo, Mexico   12th International Workshop on Clinical Pharmacology of HIV Therapy, April 13-15, 2011, Miami, FL   Eurpopean Association for the Study of the Liver March 30th - April 3rd 2011 Berlin, Germany   18th CROI Conference on Retroviruses and Opportunistic Infections February 27 - March 2, 2011 Boston, MA   The 21st Conference of the Asian Pacific Association for the Study of the Liver APASL Feb 17-20, 2011 Bangkok, Thailand   1st International Workshop on HIV and Women, January 10-11, 2011 Washington, DC   12th Intl Workshop on Adverse Reactions & Comorbidities in HIV November 5, 2010 London UK   10th International Congress on Drug Therapy in HIV Infection Glasgow November 7-11, 2010   61th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA, Hynes Convention Center October 30-November 3, 2010   First International Workshop on HIV and Aging October 4-5, 2010 Baltimore, MD   (ICAAC) 50th Interscience Conference on Antimicrobial Agents and Chemotherapy September 12-15 2010 Boston, MA   AIDS 2010 18th International AIDS Conference (IAC) July 18-23 2010 Vienna, Austria   5th International Workshop on Hepatitis C Resistance and New Compounds Boston, MA June 24-25, 2010   The 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy Boston, MA June 23-24, 2010   International HIV and Hepatitis Drug Resistance Workshop June 8-12, 2010 Dubrovnik Croatia   Microbicides Conference May 22-25, 2010 Pittsburgh, Pennsylvania   EASL 45th Annual Meeting (European Association for the Study of the Liver) April 14-18, 2010 Vienna, Austria   11th International Workshop on Clinical Pharmacology and HIV Therapy April 7-9, 2010 Sorrento, Italy   Conference of the Asian Pacific Association for the Study of the Liver 2010 20th APASL March 2010 Beijing, China   17th CROI Conference on Retroviruses and Opportunistic Infections San Francisco, CA Feb 16-19, 2010   View More Conference Reports...   Coming of AGE. A guide to ageing well with HIV - 06/15/11 La informacion Que Necesitas Sobre el VIH - 06/15/10 New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience - 06/05/07 Do you have HIV/HCV Coinfection? - 11/28/06 HIV 101 : The Basics - 11/28/06 VIH 101 : Lo Basico - in Spanish - 11/28/06 HIV 102 : Care and Treatment of HIV - 11/28/06 VIH 102 : Cuidado Y Tratamiento del VIH - in Spanish - 11/28/06 Hepatitis C and Hepatitis C Co-Infection Handbook PDF Version V 11/08/05 Download More NATAP Publications... Support provided by: Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Roche, Schering-Plough, Tibotec, Vertex   Patient Assistance Programs for HCV Therapy from the Drug Manufacturers: Pegylated Interferon and ribavirin If you cannot get reimbursement or coverage for pegylated interferon and ribavirin the manufacturers of pegylated interferon have reimbursement programs which supply free drugs if you qualify. These programs will first help you try to identify sources for reimbursement.   Schering makes Peg-Intron and ribavirin (Rebetol): Call 1-800-521-7157. Roche makes Pegasys and ribavirin (Copegus): 1-800-387-1258.   New Pegasys Patient Assistance Program   has generous provisions for patients who want to start HCV therapy with Pegasys and are uninsured. Since Roche & Genentech merged the Genentech Access Solutions P rogram took over this program starting Sept 1 2010 and as I say it is a generous transparent program.   http://www.pegasysaccesssolutions.com   866 422-2377